Ligand Pharm (LGND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,954 | 45,006 | 19,522 | 47,619 | 71,543 |
| Marketable Securities | 147,355 | 166,864 | 321,586 | 363,567 | 998,324 |
| Receivables | 39,312 | 35,038 | 91,646 | 59,064 | 41,748 |
| Inventories | 23,969 | 13,294 | 27,326 | 26,487 | 7,296 |
| Other current assets | 2,657 | 2,267 | 4,671 | 3,822 | 4,734 |
| TOTAL | $237,429 | $263,601 | $464,751 | $500,559 | $1,123,645 |
| Non-Current Assets | |||||
| PPE Net | 15,607 | 12,482 | 13,191 | 14,434 | 7,185 |
| Investments And Advances | 48,321 | 3,000 | 0 | 0 | 0 |
| Intangibles | 470,267 | 458,310 | 492,474 | 795,971 | 325,767 |
| Other Non-Current Assets | 15,592 | 25,275 | 327,174 | 51,321 | 38,318 |
| TOTAL | $549,787 | $499,067 | $832,839 | $861,726 | $371,270 |
| Total Assets | $787,216 | $762,668 | $1,297,590 | $1,362,285 | $1,494,915 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 76,695 | 0 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,427 | 5,307 | 8,403 | 3,784 | 2,420 |
| Accrued Expenses | 12,467 | 15,681 | 17,579 | 18,530 | 8,581 |
| Other current liabilities | 256 | 57 | 13,616 | 39,884 | 2,607 |
| TOTAL | $16,782 | $98,810 | $41,665 | $100,111 | $17,002 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,222 | 355 | 654 | 29,435 | 2,139 |
| Other Non-Current Liabilities | 36,455 | 35,714 | 403,910 | 488,051 | 677,744 |
| TOTAL | $69,521 | $66,373 | $434,766 | $552,649 | $710,681 |
| Total Liabilities | $86,303 | $165,183 | $476,431 | $652,760 | $727,683 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,705 | 17,077 | 16,853 | 16,612 | 16,505 |
| Common Shares | 18 | 17 | 17 | 16 | 17 |
| Retained earnings | 503,016 | 450,862 | 449,090 | 391,952 | 400,105 |
| Other shareholders' equity | -817 | -984 | -917 | -801 | -216 |
| TOTAL | $700,913 | $597,485 | $821,159 | $709,525 | $767,232 |
| Total Liabilities And Equity | $787,216 | $762,668 | $1,297,590 | $1,362,285 | $1,494,915 |